Join me as we explore Stockholm, Sweden, part of a Baltic cruise in September 2018 aboard the Marella Discovery. We visited various ports including Gothenburg, Tallinn, St Petersburg, Helsinki, ...

The Philippines is in the grip of its largest HIV outbreak on record, with 57 new infections reported every day, nearly a third of them among people below 18 years old, Health Secretary Ted Herbosa ...

As the annual U.S. Conference on HIV/AIDS (USCHA) kicks off in Washington, D.C., this week with a focus on aging with HIV, Gilead Sciences is rolling out a corresponding awareness campaign ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

Sara Herschander is a fellow for Future Perfect, Vox’s section on making the world a better place. She writes about global health, philanthropy, labor, and social movements. Botswana has been getting ...

The government plans to make the twice-a-year anti-HIV jab, lenacapavir, available at over 300 government clinics in health districts. Lenacapavir is a type of PrEP for HIV infection, which is when ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

The European Commission has formally approved a twice-yearly injection to prevent HIV, clearing the way for the jab to be rolled out across the European Union, according to drugmaker Gilead. The ...

For years, Philip Goulder has been obsessed with a particularly captivating idea: In the hunt for an HIV cure, could children hold the answers? Starting in the mid-2010s, the University of Oxford ...

For years, Philip Goulder has been obsessed with a particularly captivating idea: In the hunt for an HIV cure, could children hold the answers? Starting in the mid-2010s, the University of Oxford ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of the diverse variants of HIV. Neutralizing antibodies are proteins produced ...

Generating effective protection against HIV may require a complex vaccine consisting of a series of different viral proteins. Now, two trials of the potential components delivered via mRNA have ...